How does the FDA ensure the safety of approved cancer treatments?
The FDA continuously monitors the safety of approved cancer treatments through post-marketing surveillance, which includes:
Adverse Event Reporting: Healthcare providers and patients can report any adverse effects experienced with a drug. Post-Marketing Studies: The FDA may require additional studies to gather more information on the drug's long-term safety and effectiveness. Risk Evaluation and Mitigation Strategies (REMS): Programs designed to manage known or potential risks associated with a drug.
